Status:
COMPLETED
A Quality of Life Study re Management of Malignant Pleural Effusions
Lead Sponsor:
University Health Network, Toronto
Conditions:
Malignant Pleural Effusions
Eligibility:
All Genders
18+ years
Brief Summary
There is much data in the literature regarding optimal treatment approaches for malignant pleural effusions as assessed by patient outcomes. However, data on quality of life and satisfaction with trea...
Detailed Description
This study will compare various treatment strategies in the management of malignant pleural effusions with respect to: 1. Primary endpoint: the successful palliation of symptomatic pleural effusions ...
Eligibility Criteria
Inclusion
- symptomatic pleural effusion
- history of malignant disease
- age greater that 18 years
- consent to participate in study
Exclusion
- significant ipsilateral endobronchial disease
- prior ipsilateral, intra-pleural therapy, as defined by: prior chest tube placement for effusion, prior attempt at chemical/surgical pleurodesis, prior surgical pleurectomy
- active pulmonary or pleural infection
- granulocytes \< 1500/mm3, platelets \< 50,000/mm3
- systemic chemotherapy within 2 weeks
- allergy to talc
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT00188474
Start Date
August 1 2004
End Date
November 1 2013
Last Update
May 4 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4
2
St. Joseph's Hospital
Toronto, Ontario, Canada